- Home
- BBIO vs GTLS Comparison
BBIO vs GTLS Comparison
Compare BBIO & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- GTLS
- Stock Information
- Founded
- BBIO 2015
- GTLS 1859
- Country
- BBIO United States
- GTLS United States
- Employees
- BBIO N/A
- GTLS N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- GTLS Metal Fabrications
- Sector
- BBIO Health Care
- GTLS Industrials
- Exchange
- BBIO Nasdaq
- GTLS Nasdaq
- Market Cap
- BBIO 9.4B
- GTLS 9.0B
- IPO Year
- BBIO 2019
- GTLS 1992
- Fundamental
- Price
- BBIO $55.32
- GTLS $200.07
- Analyst Decision
- BBIO Strong Buy
- GTLS Buy
- Analyst Count
- BBIO 16
- GTLS 14
- Target Price
- BBIO $64.44
- GTLS $200.50
- AVG Volume (30 Days)
- BBIO 2.0M
- GTLS 843.7K
- Earning Date
- BBIO 11-11-2025
- GTLS 10-29-2025
- Dividend Yield
- BBIO N/A
- GTLS N/A
- EPS Growth
- BBIO N/A
- GTLS 176.90
- EPS
- BBIO N/A
- GTLS 5.39
- Revenue
- BBIO $235,812,000.00
- GTLS $4,253,100,000.00
- Revenue This Year
- BBIO $115.46
- GTLS $11.79
- Revenue Next Year
- BBIO $65.03
- GTLS $10.17
- P/E Ratio
- BBIO N/A
- GTLS $37.11
- Revenue Growth
- BBIO 7.62
- GTLS 8.95
- 52 Week Low
- BBIO $21.72
- GTLS $104.60
- 52 Week High
- BBIO $55.32
- GTLS $220.03
- Technical
- Relative Strength Index (RSI)
- BBIO 59.91
- GTLS 63.87
- Support Level
- BBIO $52.97
- GTLS $199.80
- Resistance Level
- BBIO $55.13
- GTLS $200.94
- Average True Range (ATR)
- BBIO 1.58
- GTLS 0.71
- MACD
- BBIO 0.16
- GTLS -0.47
- Stochastic Oscillator
- BBIO 84.41
- GTLS 50.90
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.